Maximal Challenges, Opportunities, and the Evolving Role of IP Professionals
From the initial filing of an application to the grant of a right - and throughout its entire lifecycle – IP rights are governed by strict and often complex deadlines. Missing just one can result in the loss of protection, with serious consequences for businesses and innovators.
IP deadlines are not just national. In addition to country-specific rules, IP practitioners must navigate international frameworks established by bodies such as the World Intellectual Property Office (WIPO) - under the Patent Cooperation Treaty (PCT) system, the European Patent Office (EPO), and other regional offices. These systems introduce their own sets of procedural deadlines, priority periods, time limits for responses, and formal requirements that must be closely monitored.
Whether it’s a priority deadline under the Paris Convention, a time limit for entering the national phase in a PCT application, or a response period for an examination report at the EPO, staying on top of these deadlines is essential for ensuring uninterrupted protection across jurisdictions.
This white paper provides a selection of key international IP deadlines to support accurate and efficient deadline management, thus helping IP professionals avoid costly mistakes and streamline their global filing strategies.
Combined offer of three compulsory seminars plus one elective module for (future) Heads of the Pharmacovigilance Department - learn the responsibilities and legal aspects of managing a PV system and its staff, and select an elective module according to your individual interests.
Combination of three selected seminars - with this qualification course, you will first gain insight into the legal aspects and general responsibilities of the Qualified Person for Pharmacovigilance (QPPV). You will then deepen your professional and practical knowledge to perform your role more effectively.
This e-Learning programme will provide you with knowledge on Good Distribution Practice in today's pharmaceutical industry
Our e-learning, specially tailored for medical device advisors, provides you with the essential knowledge to navigate your professional duties confidently and in full legal compliance.
Our e-learning, specially tailored for medical device advisors, provides you with the essential knowledge to navigate your professional duties confidently and in full legal compliance.
This e-learning programme will familiarise you with the regulatory affairs principles involved in applying for a marketing authorisation in Europe (MRP, DCP, CP) . It will also introduce you to post-authorisation duties (renewal, variation...).
Are you a specialist in the pharmaceutical industry in the area of marketing authorisation and responsible for compiling the quality documentation of active pharmaceutical ingredients (APIs) and their starting material? Then this is the right seminar for you! Including an update on the new ICH Q1, M4Q(R2) and ASMF matters, as well as new regulatory trends including ICH Q12, reliance and AI.
During our online training "Toxicology and beyond: Safety assessment in drug development" you will build a solid toxicological know-how basis and will be informed about the inclusion of toxicological data in the marketing authorisation dossier. Take the chance and participate in our interactive online training.
This online event offers a comprehensive overview of marketing authorisation and market access in the Middle East, covering key topics like market entry, intellectual property, lifecycle management, pharmacovigilance and quality considerations, with a focus on Gulf Cooperation Council, Saudi Arabia, the UAE, Jordan and Syria.
Non-clinical/clinical content in the dossier: Are you a beginner in the field and would like to feel confident working competently on modules 2, 4 and 5 in the future? Are you already an experienced specialist and would like to refresh, professionalise or "structure" your knowledge? Then you've come to the right place!
You will gain actionable insights into global market access strategies, payer evidence requirements, and health economic tools - enabling you to support strategic decision-making across diverse healthcare systems.
